Skip to search formSkip to main contentSkip to account menu

5-Lipoxygenase Inhibitor [EPC]

Known as: 5-Lipoxygenase Inhibitor 
National Institutes of Health

Related topics

Related topics

1 relation
Arachidonate 5-Lipoxygenase Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Quantification of the 5-lipoxygenase inhibitor zileuton in human plasma using high performance liquid chromatography-tandem mass spectrometry.
2007
2007
Establishment of a progesterone-sensitive cell line from human lung cancer.
For deveplopment and function of the lung, progesterone (Prog) fulfils important roles. In a recent report, immunolocalization of… 
1991
1991
THE IMMUNOSUPPRESSIVE PROPERTIES OF ENISOPROST AND A 5‐LIPOXYGENASE INHIBITOR (SC‐45662)
Metabolic derivatives of arachidonic acid such as prostaglandins and leukotrienes may alter immune responses. Enisoprost (ENO), a… 
1990
1990
Molecular biology and cloning of archidonate 5-lipoxygenase.
1988
1988
Involvement of arachidonate-dependent lipid mediators and platelet-activating factor in experimental murine contact dermatitis.
A 5-lipoxygenase inhibitor (5-LPI) and a platelet-activating factor antagonist (PAF-A) were studied in dinitrofluorobenzene (DNFB… 
1987
1987
Renal microthrombosis following endotoxin infusion may be mediated by lipoxygenase products.
Renal microvascular thrombosis following endotoxin infusion was assessed by measuring accumulation of 125I-labeled fibrinogen and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)